(ASCO2020) Ascentage Pharma Presents Latest Clinical Data of Apoptosis Targeting Drug Candidates, Showing Promising Clinical Effects with Combination Therapies
- Sunday, May 31, 2020, 7:13
- Business
- Add a comment
SUZHOU, China and ROCKVILLE, Md., May 31, 2020 /PRNewswire/ — Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company…
About the Author
adminasapcorp has written 38936 stories on this site.